2-(3,7,11,15,19,23,27-Heptamethyloctacosa-2,6,10,14,18,22,26-heptaenyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione (BioDeep_00000175563)

   

human metabolite blood metabolite


代谢物信息卡片


2-(3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

化学式: C44H66O4 (658.4960836)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 68.18%

分子结构信息

SMILES: COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O
InChI: InChI=1S/C44H66O4/c1-32(2)18-12-19-33(3)20-13-21-34(4)22-14-23-35(5)24-15-25-36(6)26-16-27-37(7)28-17-29-38(8)30-31-40-39(9)41(45)43(47-10)44(48-11)42(40)46/h18,20,22,24,26,28,30H,12-17,19,21,23,25,27,29,31H2,1-11H3

描述信息

同义名列表

2 个代谢物同义名

2-(3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione; 2-(3,7,11,15,19,23,27-Heptamethyloctacosa-2,6,10,14,18,22,26-heptaenyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Antonio Mancini, Roberto Festa, Sebastiano Raimondo, Alfredo Pontecorvi, Gian Paolo Littarru. Hormonal influence on coenzyme Q(10) levels in blood plasma. International journal of molecular sciences. 2011; 12(12):9216-25. doi: 10.3390/ijms12129216. [PMID: 22272129]
  • Yin-Ku Lin, Zih-Rou Huang, Rou-Zi Zhuo, Jia-You Fang. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. International journal of nanomedicine. 2010 Mar; 5(?):117-28. doi: 10.2147/ijn.s9155. [PMID: 20309398]
  • E Y Kang, J W Choi, H S Gwak, I K Chun. Comparison of bioavailability of two ubidecarenone products in healthy Korean volunteers. International journal of clinical pharmacology and therapeutics. 2009 Mar; 47(3):207-14. doi: 10.5414/cpp47207. [PMID: 19281730]
  • Matthew Cooke, Mike Iosia, Thomas Buford, Brian Shelmadine, Geoffrey Hudson, Chad Kerksick, Christopher Rasmussen, Mike Greenwood, Brian Leutholtz, Darryn Willoughby, Richard Kreider. Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. Journal of the International Society of Sports Nutrition. 2008 Mar; 5(?):8. doi: 10.1186/1550-2783-5-8. [PMID: 18318910]
  • Heiner K Berthold, Ali Naini, Salvatore Di Mauro, Maarit Hallikainen, Helena Gylling, Wilhelm Krone, Ioanna Gouni-Berthold. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial. Drug safety. 2006; 29(8):703-12. doi: 10.2165/00002018-200629080-00007. [PMID: 16872244]
  • R Macarez, S Bazin, D Lagauche, B Soullié, P Giordano, F May, B Guigon. [Onset of Leber's hereditary optic neuropathy in association with borreliosis]. Journal francais d'ophtalmologie. 2005 Dec; 28(10):1095-100. doi: 10.1016/s0181-5512(05)81144-1. [PMID: 16395203]
  • F Carli, E E Chiellini, B Bellich, S Macchiavelli, G Cadelli. Ubidecarenone nanoemulsified composite systems. International journal of pharmaceutics. 2005 Mar; 291(1-2):113-8. doi: 10.1016/j.ijpharm.2004.07.048. [PMID: 15707737]
  • Iain P Hargreaves, Andrew J Duncan, Simon J R Heales, John M Land. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. Drug safety. 2005; 28(8):659-76. doi: 10.2165/00002018-200528080-00002. [PMID: 16048353]
  • H Bunjes, M Drechsler, M H Koch, K Westesen. Incorporation of the model drug ubidecarenone into solid lipid nanoparticles. Pharmaceutical research. 2001 Mar; 18(3):287-93. doi: 10.1023/a:1011042627714. [PMID: 11442266]
  • S Zhou, E Chan. Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats. Drug metabolism and drug interactions. 2001; 18(2):99-122. doi: 10.1515/dmdi.2001.18.2.99. [PMID: 11460879]